黑料网

Congratulations to Tom Kash on being named the new Director of the Bowles Center for Alcohol Studies!

The Bryan Roth lab got some nice press for their recent Nature paper, revealing structural details of his chemogenetic technology called DREADD 鈥� designer receptors exclusively activated by designer drugs - that recognize drug-like but physiologically inert compounds. Postdoc Shicheng Zhang, PhD, led this research published in Nature.

Dr. Fennell defended her thesis, 鈥淧rofiling the Multi-omic Response to Mitochondrial Protease ClpP Activation in Triple-Negative Breast Cancer Cells,鈥� November 22!

Congrats to our second year students on passing their qualification exams!

There was a lot of great tasting food and everyone had a good time! Thanks to all who brought food!

Jude Samulski's pioneering work in gene therapy is honored by the The European Society of Gene and Cell Therapy with its 2022 Founders Award. Congratulations, Jude!

Our grad students visited Spring Hill Goat Farm for some fall fun carving pumpkins with baby goats!

The 黑料网 has received the 2022 Health Professions Higher Education Excellence in Diversity (HEED) Award from INSIGHT Into Diversity magazine.

The Roth Lab and collaborators from UC San Francisco, Yale, Duke, and Stanford developed a new compound that hits the same brain cell target as psychedelic drugs, triggering long-lasting anti-depressant action without psychedelic effects in mice. Kuglae Kim is co-first author of the Nature paper.

The Lustgarten Foundation has awarded its inaugural Lustgarten Equity, Accessibility, and Diversity (LEAD) Project grant to Jen Jen Yeh, MD, in support of her聽PROmoting CLinicAl TrIal EngageMent for Pancreatic Cancer App Study (PROCLAIM Study).